Iptacopan in IgA Nephropathy — Final 24-Month Data

Jonathan Barratt

Necmi Eren

Kocaeli University, Kocaeli, Turkey

Naoki Kashihara

Kawasaki Medical School, Okayama, Japan

Bart Maes

AZ Delta, Roeselare, Belgium

Dana V. Rizk

University of Alabama at Birmingham, Birmingham

Brad Rovin

Ohio State University Wexner Medical Center, Columbus

Hernán Trimarchi

Hospital Británico, Buenos Aires

Hong Zhang

Weiming Wang

Ruijin Hospital, Shanghai Jiaotong University, Shanghai

Ismail Kocyigit

Erciyes University Medical School, Kayseri, Turkey

Chuanming Hao

Huashan Hospital, Fudan University, Shanghai

Vladimir Tesař

First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic

Kenan Turgutalp

School of Medicine, Mersin University, Mersin, Turkey

Li Yang

Guangqun Xing

Affiliated Hospital of Qingdao University, Qingdao, China

Valter Duro Garcia

Latin American Dialysis and Renal Transplant Registry from National Societies of Nephrology, Porto Allegre, Brazil

Seung Hyeok Han

Yonsei University College of Medicine, Seoul, South Korea

Wanhong Lu

First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Antonio Pisani

Nephrology Unit, University of Naples Federico II, Naples, Italy

Julia Weinmann-Menke

Frank Eitner

Novartis Pharma, Basel, Switzerland

Nicolas Guerard

Novartis Pharma, Basel, Switzerland

Dmytro Butylin

Novartis Pharma, Basel, Switzerland

Luca Monaco

Novartis Pharma, Basel, Switzerland

Emil Scosyrev

Novartis Pharmaceuticals, East Hanover, NJ

Annabel Magirr

Novartis Pharma, Basel, Switzerland

Ronny Renfurm

Novartis Pharma, Basel, Switzerland

Thomas Hach

Novartis Pharma, Basel, Switzerland

Vlado Perkovic

University of New South Wales, Sydney